| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/29/2009 | US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 12/29/2009 | US7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders |
| 12/29/2009 | US7638537 Pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 12/29/2009 | US7638528 Drug delivery agent containing an anticarcinogenic agent such as mitoxanthrone, doxorubicin, methotrexate etc. covalently linked to a compound via an ester, amido or carabamte linkage to the S, O or amino group of the compound |
| 12/29/2009 | US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 12/29/2009 | US7638518 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 12/29/2009 | US7638511 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| 12/29/2009 | US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation |
| 12/29/2009 | US7638497 For enhancing apoptosis and treating proliferative disorders; antitumor agents |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638272 administering a polypeptide to the cancer cells of the mammal in vivo for sensitizing the cancer cells to the therapeutic chemotherapy, radiation treatment; gene expressed polypeptide; secreted protein acidic and rich in cystein |
| 12/29/2009 | US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 12/29/2009 | CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
| 12/29/2009 | CA2429720C Tricyclic compounds useful for the inhibition of farnesyl protein transferase |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2424797C Methods of inducing cancer cell death and tumor regression |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/29/2009 | CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/29/2009 | CA2410311C Barbituric acid analogs as therapeutic agents |
| 12/29/2009 | CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
| 12/29/2009 | CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels |
| 12/29/2009 | CA2339054C E-isomeric fullerene derivatives |
| 12/29/2009 | CA2300208C Immunostimulatory and metastasis inhibiting fermented vegetal material |
| 12/29/2009 | CA2299548C Composition and method for regulating cell proliferation and cell death |
| 12/29/2009 | CA2282720C Dolastatin-15 derivatives in combination with taxanes |
| 12/29/2009 | CA2264802C Antioxidant derived from lentil and its preparation and uses |
| 12/24/2009 | US20090320148 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same |
| 12/24/2009 | US20090318568 Adherent coating for tissue surface and/or trans-tissue surface substance delivery |
| 12/24/2009 | US20090318566 Gossypol derivatives, production method thereof and uses of same |
| 12/24/2009 | US20090318553 Use Of Docosahexaenoic Glycerides For The Treatment Of Tumorous Diseases |
| 12/24/2009 | US20090318551 Uses of analogs of 3-o-acetyl-11-keto-beta-boswellic acid |
| 12/24/2009 | US20090318543 C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes |
| 12/24/2009 | US20090318541 such as tert-butyl [(1S)-1-benzyl-2-({2-[(hydroxyamino)carbonyl]-1-benzothien-6-yl}amino)ethyl]carbamate, exhibiting histone deacetylase inhibitory activity, used for treating cancer, autoimmune, allergic, inflammatory and neurodegenerative diseases |
| 12/24/2009 | US20090318535 BETA -TrCP1, BETA -TrCP2 AND RSK1 OR RSK2 INHIBITORS AND METHODS FOR SENSITIZING TARGET CELLS TO APOPTOSIS |
| 12/24/2009 | US20090318511 Selective hydroxamate based mmp inhibitors |
| 12/24/2009 | US20090318500 4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer |
| 12/24/2009 | US20090318489 Aporphine compounds and pharmaceutical use thereof |
| 12/24/2009 | US20090318472 Aminopyrazine derivatives and compositions |
| 12/24/2009 | US20090318471 New Salts and Crystalline Salt Forms of an Indolinone Derivative |
| 12/24/2009 | US20090318468 Pyrazole compounds 436 |
| 12/24/2009 | US20090318457 Methods of Using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318450 Compositions for modulating a kinase cascade and methods of use thereof |
| 12/24/2009 | US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy |
| 12/24/2009 | US20090318444 Tetrahydro- and dihydroquinazolinones |
| 12/24/2009 | US20090318443 Kinase inhibitors |
| 12/24/2009 | US20090318442 Thiazolyl-and oxazolyl-isoquinolinones and methods for using them |
| 12/24/2009 | US20090318441 Pyrrolopyrimidine Compounds and Their Uses |
| 12/24/2009 | US20090318438 Heterocyclic compounds and their use as anticancer agents |
| 12/24/2009 | US20090318436 Fused heterocyclic derivatives and methods of use |
| 12/24/2009 | US20090318434 Composition and process - 356 |
| 12/24/2009 | US20090318428 Heteroaryl derivatives as protein kinase inhibitors |
| 12/24/2009 | US20090318409 Pyrrolidine inhibitors of iap |
| 12/24/2009 | US20090318407 Inhibitors of protein kinases |
| 12/24/2009 | US20090318402 Ruthenium (ii) compounds |
| 12/24/2009 | US20090318400 Method for inhibiting tumor growth with dehydrosulphurenic acid extracted from antrodia cinnamomea |
| 12/24/2009 | US20090318390 Combinations comprising epothilones and pharmaceutical uses thereof |
| 12/24/2009 | US20090318388 Method of activation of oxazaphosphorines |
| 12/24/2009 | US20090318387 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS |
| 12/24/2009 | US20090318373 Receptor-type kinase modulators and methods of use |
| 12/24/2009 | US20090318370 Novel glycoconjugated chlorin derivatives and method of producing the same |
| 12/24/2009 | US20090318367 Use of SH2 STAT3/STAT1 Peptidomimetics as Anticancer Drugs |
| 12/24/2009 | US20090318365 Metastin derivatives and use thereof |
| 12/24/2009 | US20090318362 Oligomeric compounds for the modulation of survivin expression |
| 12/24/2009 | US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 12/24/2009 | US20090318350 Pan-her antagonists and methods of use |
| 12/24/2009 | US20090318346 BIVALENT ErbB LIGAND BINDING MOLECULES AND METHODS FOR THEIR PREPARATION AND USE |
| 12/24/2009 | US20090318329 Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors |
| 12/24/2009 | US20090317479 Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
| 12/24/2009 | US20090317475 Combination antitumor therapies |
| 12/24/2009 | US20090317472 Controlled releases of actives in skin |
| 12/24/2009 | US20090317456 Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer |
| 12/24/2009 | US20090317440 Anti-mitotic anti-proliferative compounds |
| 12/24/2009 | US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes |
| 12/24/2009 | US20090317416 Antibodies, vaccines, tumor antigens |
| 12/24/2009 | US20090317411 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment |
| 12/24/2009 | US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/24/2009 | US20090317408 Ligand conjugated thermotherapy susceptors and methods for preparing same |
| 12/24/2009 | US20090317407 Augmentation of immune response to cancer vaccine |
| 12/24/2009 | US20090317405 Antibody and uses thereof |
| 12/24/2009 | US20090317403 Use of CSF-1 Inhibitors |
| 12/24/2009 | US20090317401 Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2 |
| 12/24/2009 | US20090317391 Cancer Related Genes (PTPE) |
| 12/24/2009 | US20090317384 Methods of using death receptor ligands and cd20 antibodies |
| 12/24/2009 | US20090317383 Cancer treatment method |
| 12/24/2009 | US20090317374 Composition containing arazyme for the prevention and treatment of cancer |
| 12/24/2009 | US20090317362 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 12/24/2009 | US20090317359 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of raf kinase |
| 12/24/2009 | US20090317358 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 12/23/2009 | WO2009155614A2 A magnetic breather pump and a method for treating a brain tumor using the same |
| 12/23/2009 | WO2009155556A2 Crkl targeting peptides |
| 12/23/2009 | WO2009155535A2 Compositions, methods and kits for eliciting an immune response |
| 12/23/2009 | WO2009155527A2 Phosphatidylinositol 3 kinase inhibitors |
| 12/23/2009 | WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |